1887
Preview this article:
Zoom in
Zoomout

Authors' reply, Page 1 of 1

| /docserver/preview/fulltext/micro/152/7/1895-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.29045-0
2006-07-01
2019-10-24
Loading full text...

Full text loading...

/deliver/fulltext/micro/152/7/1895.html?itemId=/content/journal/micro/10.1099/mic.0.29045-0&mimeType=html&fmt=ahah

References

  1. Duverger, A., Jackson, R. J., van Ginkel, F. W. & 7 other authors ( 2006; ). Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens. J Immunol 176, 1776–1783.[CrossRef]
    [Google Scholar]
  2. Hatheway, C. L. ( 1976; ). Toxoid of Clostridium botulinum type F: purification and immunogenicity studies. Appl Environ Microbiol 31, 234–242.
    [Google Scholar]
  3. Hatheway, C. L., McCroskey, L. M., Lombard, G. L. & Dowell, V. R., Jr ( 1981; ). Atypical toxin variant of Clostridium botulinum type B associated with infant botulism. J Clin Microbiol 14, 607–611.
    [Google Scholar]
  4. Lee, J. C., Yokota, K., Arimitsu, H. & 7 other authors ( 2005; ). Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin. Microbiology 151, 3739–3747.[CrossRef]
    [Google Scholar]
  5. Oguma, K., Syuto, B., Iida, H. & Kubo, S. ( 1980; ). Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains. Infect Immun 30, 656–660.
    [Google Scholar]
  6. Oguma, K., Agui, T., Syuto, B., Kimura, K., Iida, H. & Kubo, S. ( 1982; ). Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum. Infect Immun 38, 14–20.
    [Google Scholar]
  7. Oguma, K., Murayama, S., Syuto, B., Iida, H. & Kubo, S. ( 1984; ). Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies. Infect Immun 43, 584–588.
    [Google Scholar]
  8. Sugiyama, H., Ohishi, I. & Dasgupta, B. R. ( 1974; ). Evaluation of type A botulinal toxin assays that use antitoxin to crystalline toxin. Appl Microbiol 27, 333–336.
    [Google Scholar]
  9. Sun, H. X. ( 2006; ). Adjuvant effect of Achyranthes bidentata saponins on specific antibody and cellular response to ovalbumin in mice. Vaccine 24, 3432–3439.[CrossRef]
    [Google Scholar]
  10. Suzuki, T., Watanabe, T., Mutoh, S., Hasegawa, K., Kouguchi, H., Sagane, Y., Fujinaga, Y., Oguma, K. & Ohyama, T. ( 2005; ). Characterization of the interaction between subunits of the botulinum toxin complex produced by serotype D through tryptic susceptibility of the isolated components and complex forms. Microbiology 151, 1475–1483.[CrossRef]
    [Google Scholar]
  11. Torii, Y., Tokumaru, Y., Kawaguchi, S., Izumi, N., Maruyama, S., Mukamoto, M., Kozaki, S. & Takahashi, M. ( 2002; ). Production and immunogenic efficacy of botulinum tetravalent (A, B, E, F) toxoid. Vaccine 20, 2556–2561.[CrossRef]
    [Google Scholar]
  12. Vertiev, Y. V., Zdanovsky, A. G., Shevelev, A. B., Borinskaya, S. A., Gening, E. L., Martin, T., Ivanov, P. A. & Yankovsky, N. K. ( 2001; ). Recombinant Listeria strains producing the nontoxic L-chain of botulinum neurotoxin A in a soluble form. Res Microbiol 152, 563–567.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.29045-0
Loading
/content/journal/micro/10.1099/mic.0.29045-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error